can semaglutide cause irritability Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss The Boom in New Weight

Pricing Differences : Ozempic costs $1,200$1,500 per month, while compounded semaglutide ranges from $200$400 per month

Tirzepatide adds GIP (glucose-dependent insulinotropic polypeptide) receptor agonism

Chewing food thoroughly and eating slowly allows better recognition of satiety signals, which are enhanced by the medication

GLP-1 drugs' proven ability to deliver superior glucose control, weight reduction benefits, and cardiovascular protection makes them essential treatments for modern diabetes management and metabolic health applications

In a phase 2 clinical trial for obesity, 26 weeks of efinopegdutide (doses 5 to 10mg) resulted in up to 11.8% WL in people with obesity (without diabetes) compared to 7.5% WL with liraglutide 3 mg and 1.8% WL with placebo [77, 78]

Patients should be carefully monitored, and the risks weighed against the benefits on a case-by-case basis, particularly when used outside of its original medical context